CD4 and infection: Even if pre-existing cross immunity by other HCoVs (human coronaviruses) to SCOV2 infection is debatable, there is accumulated evidence that HCoV-specific SCOV2 cross-reactive CD4+ T cells may trigger and enhance humoral immune responses in SCOV2 infection (138).